{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,20]],"date-time":"2026-06-20T10:22:36Z","timestamp":1781950956722,"version":"3.54.5"},"reference-count":12,"publisher":"Oxford University Press (OUP)","issue":"5","license":[{"start":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T00:00:00Z","timestamp":1778112000000},"content-version":"vor","delay-in-days":7,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,4,30]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Fluoropyrimidines, such as 5-fluorouracil (5-FU), when used in combination with bevacizumab are associated with diverse cardiotoxic effects, including vasospasm, myocarditis, and myopericarditis. These toxicities may closely mimic acute coronary syndrome, creating diagnostic uncertainty and risk of inappropriate management. Cardiac magnetic resonance (CMR) is central in distinguishing inflammatory myocardial injury from ischaemic pathology.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Case summary<\/jats:title>\n                    <jats:p>A 71-year-old man undergoing long-term maintenance FOLFIRI\u2013bevacizumab for metastatic colorectal cancer presented with acute chest pain and inferior ST-segment elevation 12 days after chemotherapy. Coronary angiography demonstrated non-obstructive coronary artery disease without a culprit lesion. Serial electrocardiographies showed dynamic evolution from ST elevation to widespread T-wave inversion, while peak high-sensitivity troponin reached 457\u2005ng\/L. Initial echocardiography revealed normal left ventricular ejection fraction. Cardiac magnetic resonance performed 1 week later demonstrated subepicardial late gadolinium enhancement and elevated regional T2 signal in the lateral segments, fulfilling the 2018 Lake Louise criteria for myopericarditis. Chemotherapy was withheld, and the patient was treated with colchicine, beta-blockade, and intermittent nitrates. Six-month follow-up imaging showed complete recovery of systolic function, permitting safe reintroduction of FOLFIRI\u2013bevacizumab.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Discussion<\/jats:title>\n                    <jats:p>This case highlights a diagnostically challenging presentation of fluoropyrimidine-associated myopericarditis masquerading as ST-elevated myocardial infarction (STEMI). Synergistic endothelial injury from 5-FU and bevacizumab may lower the threshold for cardiotoxicity even after multiple well-tolerated cycles. Multimodality imaging, particularly CMR, was essential in confirming myocardial inflammation, excluding ischaemia, and guiding treatment decisions. Increased awareness of chemotherapy-related STEMI mimics is critical to prevent unnecessary interventions and allow safe continuation of oncologic therapy following cardiac recovery.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/ehjcr\/ytag326","type":"journal-article","created":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T11:42:27Z","timestamp":1778067747000},"source":"Crossref","is-referenced-by-count":1,"title":["An oncologic cardiotoxicity masquerading as ST-elevated myocardial infarction: a case report"],"prefix":"10.1093","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0009-0006-9275-1005","authenticated-orcid":false,"given":"Amarpal Karamjit","family":"Singh","sequence":"first","affiliation":[{"name":"Department of Medicine, University of Melbourne , Grattan Street, Parkville, Melbourne, Victoria 3010 ,","place":["Australia"]},{"name":"Department of Cardiology, Northern Health , 185 Cooper Street, Epping, Melbourne, Victoria 3076 ,","place":["Australia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rifly","family":"Rafiudeen","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of Melbourne , Grattan Street, Parkville, Melbourne, Victoria 3010 ,","place":["Australia"]},{"name":"Department of Cardiology, Northern Health , 185 Cooper Street, Epping, Melbourne, Victoria 3076 ,","place":["Australia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiew","family":"Wong","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of Melbourne , Grattan Street, Parkville, Melbourne, Victoria 3010 ,","place":["Australia"]},{"name":"Department of Cardiology, Northern Health , 185 Cooper Street, Epping, Melbourne, Victoria 3076 ,","place":["Australia"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,5,7]]},"reference":[{"key":"2026052314563076700_ytag326-B1","first-page":"2346","article-title":"Mechanism of cell death following thymidylate synthase inhibition: 2\u2019-deoxyuridine-5\u2019-triphosphate accumulation, DNA damage, and growth inhibition following exposure to CB3717 and dipyridamole","volume":"51","author":"Curtin","year":"1991","journal-title":"Cancer Res"},{"key":"2026052314563076700_ytag326-B2","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/S0021-5198(19)52945-6","article-title":"Cardiotoxic effects of 5-fluorouracil in the guinea pig","volume":"30","author":"Matsubara","year":"1980","journal-title":"Jpn J Pharmacol"},{"key":"2026052314563076700_ytag326-B3","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1191\/0960327106ht628oa","article-title":"Cardiac lesions induced by 5-fluorouracil in the rabbit","volume":"25","author":"Tsibiribi","year":"2006","journal-title":"Hum Exp Toxicol"},{"key":"2026052314563076700_ytag326-B4","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1042\/CS20200309","article-title":"Interactions between cardiology and oncology drugs in precision cardio-oncology","volume":"135","author":"Kamaraju","year":"2021","journal-title":"Clin Sci"},{"key":"2026052314563076700_ytag326-B5","doi-asserted-by":"crossref","first-page":"3158","DOI":"10.1016\/j.jacc.2018.09.072","article-title":"Cardiovascular magnetic resonance in nonischemic myocardial inflammation: expert recommendations","volume":"72","author":"Ferreira","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"2026052314563076700_ytag326-B6","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1007\/s00392-018-1386-0","article-title":"Recovery from left ventricular dysfunction was associated with the early introduction of heart failure medical treatment in cancer patients with anthracycline-induced cardiotoxicity","volume":"108","author":"Ohtani","year":"2018","journal-title":"Clin Res Cardiol"},{"key":"2026052314563076700_ytag326-B7","doi-asserted-by":"crossref","first-page":"2536","DOI":"10.1016\/j.jacc.2017.09.1096","article-title":"Cardiovascular complications of cancer therapy: best practices in diagnosis, prevention, and management: part 1","volume":"70","author":"Chang","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"2026052314563076700_ytag326-B8","doi-asserted-by":"crossref","first-page":"4229","DOI":"10.1093\/eurheartj\/ehac244","article-title":"2022 ESC guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS)","volume":"43","author":"Lyon","year":"2022","journal-title":"Eur Heart J"},{"key":"2026052314563076700_ytag326-B9","first-page":"1063","article-title":"Expert consensus for multimodality imaging evaluation of adult patients during and after cancer therapy: a report from the American Society of Echocardiography and the European Association of Cardiovascular Imaging","volume":"15","author":"Plana","year":"2014","journal-title":"J Am Soc Echocardiogr"},{"key":"2026052314563076700_ytag326-B10","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1200\/JCO.2007.13.3934","article-title":"Individual fluorouracil dose adjustment based on pharmacokinetic follow-up compared with conventional dosage: results of a multicenter randomized trial of patients with metastatic colorectal cancer","volume":"26","author":"Gamelin","year":"2008","journal-title":"J Clin Oncol"},{"key":"2026052314563076700_ytag326-B11","doi-asserted-by":"crossref","first-page":"3720","DOI":"10.1093\/eurheartj\/ehad191","article-title":"2023 ESC guidelines for the management of acute coronary syndromes","volume":"44","author":"Byrne","year":"2023","journal-title":"Eur Heart J"},{"key":"2026052314563076700_ytag326-B12","doi-asserted-by":"crossref","first-page":"3952","DOI":"10.1093\/eurheartj\/ehaf192","article-title":"2025 ESC guidelines for the management of myocarditis and pericarditis","volume":"46","author":"Schulz-Menger","year":"2025","journal-title":"Eur Heart J"}],"container-title":["European Heart Journal - Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ehjcr\/advance-article-pdf\/doi\/10.1093\/ehjcr\/ytag326\/68238203\/ytag326.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ehjcr\/article-pdf\/10\/5\/ytag326\/68238203\/ytag326.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ehjcr\/article-pdf\/10\/5\/ytag326\/68238203\/ytag326.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,23]],"date-time":"2026-05-23T18:56:38Z","timestamp":1779562598000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ehjcr\/article\/doi\/10.1093\/ehjcr\/ytag326\/8671782"}},"subtitle":[],"editor":[{"given":"Christoph","family":"Jensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]},{"given":"Elias Noel","family":"Andrade-Cuellar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]},{"given":"Giuseppe","family":"Verolino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]},{"given":"Jan","family":"Henzel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]},{"given":"Deepti","family":"Ranganathan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2026,4,30]]},"references-count":12,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,4,30]]}},"URL":"https:\/\/doi.org\/10.1093\/ehjcr\/ytag326","relation":{},"ISSN":["2514-2119"],"issn-type":[{"value":"2514-2119","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,5]]},"published":{"date-parts":[[2026,4,30]]},"article-number":"ytag326"}}